results
-
Neuro
Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure
Findings, Presented at Annual American Society of Pain & Neuroscience Conference, Demonstrate Significant and Durable Relief of Chronic Vertebrogenic Low…
Read More » -
Spine
Viseon Inc. Announces Preliminary Results of Surgeon Experience Database Utilizing MaxView® System During Minimally Invasive Lateral Spine Surgery
November 30, 2022 IRVINE, Calif.–(BUSINESS WIRE)–Today Viseon Inc. announced preliminary results from the clinical use of the MaxView® intraoperative imaging technology…
Read More » -
Recon
Zimmer Biomet Announces One-Year Data from mymobility® Clinical Study at 2022 AAHKS Annual Meeting
One-Year Results Reinforce Interim Findings: mymobility Remote Care Management Platform on Apple Watch and iPhone Yielded Similar Outcomes as Traditional Care…
Read More » -
Spine
Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System
Initial results show ZIP device to be effective and safe CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Aurora Spine…
Read More » -
Neuro
Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™
Data continue to show compelling efficacy and safety, including improvement on all key measures of pain and disability, as compared…
Read More » -
Biologics
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study
–Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients who Underwent the StemSpine® Procedure for Treating…
Read More » -
Biologics
Regenexx Publishes Mid-term Results of Its Randomized Controlled Trial Showing Its Perc-ACLR Procedure Can Help Patients Avoid Surgical ACL Reconstruction
DES MOINES, Iowa, Aug. 10, 2022 /PRNewswire/ — Regenexx®, a research-driven interventional orthobiologics network of physicians performing regenerative orthopedic procedures, has published…
Read More » -
Recon
New Study Shows No Revisions and a Low Complication Rate for Exactech’s Vantage® Total Ankle Fixed Bearing System
April 14, 2022 GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement…
Read More » -
Biologics
Kolosis BIO Announces 2021 Results
• Kolosis bone grafts available in over 270 hospitals and surgical facilities in 46 states • Grafts utilized in approximately 6000…
Read More » -
Robotics
Presentation at SMISS Plenary Session of SpineGuard’s DSG® Robotic Technology Confirming Excellent Outcomes in Bone Breach Detection
November 15, 2021 PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG…
Read More » -
Spine
Premia Spine’s TOPS™ Spinal Arthroplasty System Yields Positive Patient Outcomes at 6 Weeks Through 12 Months
Intermediate clinical study results presented at SMISS 2021 November 4, 2021 NORWALK, Conn.–(BUSINESS WIRE)–Premia Spine, a medical technology company aiming…
Read More » -
Recon
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal®…
Read More » -
Spine
NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery
Peer-reviewed data results from multi-center FDA Investigational Device Exemption study reiterate disc’s superiority to ACDF SAN DIEGO, Sept. 9, 2021 /PRNewswire/ —…
Read More » -
Biologics
Cerapedics Announces Publication of Results of Study Evaluating the Cost-Effectiveness of i-FACTOR vs. Local Autologous Bone in ACDF Surgery
Data published in ClinicoEconomics and Outcomes Research show that the novel i-FACTOR is not only cost-effective compared to autograft in…
Read More » -
Biologics
Bone Therapeutics provides update on the progress of clinical studies
REGULATED INFORMATION JTA-004 Phase III top-line results planned first half September ALLOB Phase IIb currently on track but recruitment slow…
Read More »